About
Zenasbio is a biopharmaceutical company developing investigational therapies for autoimmune diseases, including monoclonal antibodies and small molecule BTK inhibitors targeting unmet medical needs.
Explore Zenasbio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.